ZWQ-31852-57313

2 vaccinations 10 coded responses 11 check-ins 10 free-text entries 5 call cases

Sex: Female
Age at first dose: 51-55
ZIP prefix: 981 / WA
Registered: 2021-04-05

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-05
Registered in v-safe
2021-04-07
Dose 1 — Pfizer-BioNTech
2021-04-07
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-04-08
Survey response — days 1–6 daily, dose 1
MedDRA: Erythema — Feeling: Fair · Site: Pain · Fatigue or tiredness

Free text: Had a short bout of red skin on face, neck and arms last night, but it went away by this morning

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-09
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness, Dyspnoea, Erythema, Rash vesicular — Feeling: Poor · Site: Redness · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Spider web, vascular rash on arms and legs. Redness on neck, face and upper arms. Dizziness and slight shortness of breath.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-09
Report sent to call center — days 1–6 daily, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-11
Survey response — days 1–6 daily, dose 1
MedDRA: Petechiae, Pre-existing disease, Self-medication — Feeling: Fair · Site: Redness · Fatigue or tiredness, Rash, not including the immediate area around the injection site

Free text: Must take Benadryl to keep vascular rash in check. Noticed emergence of petechiae in spots on the skin

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-12
Survey response — days 1–6 daily, dose 1
MedDRA: Rash, Self-medication — Feeling: Fair · Site: Redness · Rash, not including the immediate area around the injection site

Free text: Still in Benadryl to keep vasculitic type rash under control. Notice formation of petichae

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-16
Survey response — day 7, dose 1
MedDRA: Rash, Self-medication — Feeling: Fair · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Free text: Still dealing with the veiny under the skin rash and still on Benadryl

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-21
Survey response — day 14, dose 1
MedDRA: Dizziness, Livedo reticularis, Pain, Vasculitic rash — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Vasculitic rash continued, with some dizziness. This is not an itchy raised rash, it is under the skin mottling in vein like pattern and it aches

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-21
Report sent to call center — day 14, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-19
Survey response — day 42, dose 1
MedDRA: Livedo reticularis, Rash erythematous, Spider vein, Vasculitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Effects of the first vaccine included a type of vasculitis as well as levido reticularis. There have also been production of new spider veins and small reddish spots on my skin. I am not cleared for the 2nd shot at this time

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-19
Report sent to call center — day 42, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-09-27
Dose 2 — Pfizer-BioNTech
2021-10-08
Survey response — 6 months, dose 1
MedDRA: Livedo reticularis, Phlebitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Levido reticularis did not go away and vein inflammation is still also present

MedDRA releases: 2024-11 · check-in free text available
2021-10-08
Report sent to call center — 6 months, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-10-10
Survey response — day 7, dose 2
MedDRA: Condition aggravated, Pre-existing disease, Vascular pain — Feeling: Fair · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Levido reticularis has returned and inflamed veins, as well as aching in areas where the veins are prominent (legs and arms)

MedDRA releases: 2024-11 · check-in free text available
2021-10-10
Report sent to call center — day 7, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-10-11
Call 1 — Left Voicemail
2021-10-30
Survey response — day 28, dose 2
MedDRA: Condition aggravated, Phlebitis, Pre-existing disease — Feeling: Fair

Free text: Levido reticularis got a bit worse - may be easing off some now. Still have inflamed veins as well.

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-07	Pfizer-BioNTech
2	2021-09-27	Pfizer-BioNTech	No

Call center

5 call center cases

5 unsuccessful

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-08

Systemic reaction (other): Had a short bout of red skin on face, neck and arms last night, but it went away by this morning

2021-04-09

Systemic reaction (other): Spider web, vascular rash on arms and legs. Redness on neck, face and upper arms. Dizziness and slight shortness of breath.

2021-04-11

Systemic reaction (other): Must take Benadryl to keep vascular rash in check. Noticed emergence of petechiae in spots on the skin

2021-04-12

Systemic reaction (other): Still in Benadryl to keep vasculitic type rash under control. Notice formation of petichae

Release 7 — day 7, dose 1

2021-04-16

Systemic reaction (other): Still dealing with the veiny under the skin rash and still on Benadryl

Release 7 — day 14, dose 1

2021-04-21

Symptoms: Vasculitic rash continued, with some dizziness. This is not an itchy raised rash, it is under the skin mottling in vein like pattern and it aches

Release 8 — day 42, dose 1

2021-05-19

Symptoms: Effects of the first vaccine included a type of vasculitis as well as levido reticularis. There have also been production of new spider veins and small reddish spots on my skin. I am not cleared for the 2nd shot at this time

Release 10 — 6 months, dose 1

2021-10-08

Symptoms: Levido reticularis did not go away and vein inflammation is still also present

Release 10 — day 7, dose 2

2021-10-10

Systemic reaction (other): Levido reticularis has returned and inflamed veins, as well as aching in areas where the veins are prominent (legs and arms)

Release 10 — day 28, dose 2

2021-10-30

Symptoms: Levido reticularis got a bit worse - may be easing off some now. Still have inflamed veins as well.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Condition aggravated	·	·	✓
SD	Dizziness	✓	✓	✓
SD	Livedo reticularis	✓	✓	✓
SD	Pain	✓	✓	✓
SD	Phlebitis	·	·	✓
SD	Pre-existing disease	·	·	✓
SD	Rash erythematous	✓	✓	✓
SD	Spider vein	✓	✓	✓
SD	Vasculitic rash	✓	✓	✓
SD	Vasculitis	✓	✓	✓
SRO	Condition aggravated	·	·	✓
SRO	Dizziness	✓	✓	✓
SRO	Dyspnoea	✓	✓	✓
SRO	Erythema	✓	✓	✓
SRO	Petechiae	✓	✓	✓
SRO	Pre-existing disease	✓	✓	✓
SRO	Rash	✓	✓	✓
SRO	Rash vesicular	✓	✓	✓
SRO	Self-medication	✓	✓	✓
SRO	Vascular pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release